(Q33866383)

29 July 2017

1 reference

title

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy (English)

1 reference

29 July 2017

0 references

Giada Sebastiani

1

1 reference

PubMed ID

16773685

29 July 2017

Alfredo Alberti

series ordinal

2

1 reference

PubMed ID

16773685

29 July 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

World Journal of Gastroenterology

29 July 2017

1 reference

29 July 2017

12

1 reference

29 July 2017

3682-3694

1 reference

29 July 2017

23

1 reference

Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B.

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Hepatocyte transplantation for acute and chronic liver diseases.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Evaluation of liver fibrosis: a concise review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

SLC11A1 promoter gene polymorphisms and fibrosis progression in chronic hepatitis C.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Liver fibrosis -- from bench to bedside

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Role of liver biopsy in management of chronic hepatitis C: a systematic review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Alcoholic liver disease: new insights into mechanisms and preventative strategies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Natural history of hepatitis C.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Cytokines in viral hepatitis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Noninvasive diagnosis of hepatic fibrosis or cirrhosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

The role of laparoscopy in the diagnosis of cirrhosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Acetaldehyde-induced stimulation of collagen synthesis and gene expression is dependent on conditions of cell culture: studies with rat lipocytes and fibroblasts

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Chronic hepatitis: morphology and nomenclature.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Experimental liver cirrhosis induced by alcohol and iron

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Sampling Variability on Percutaneous Liver Biopsy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

28 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Reproducibility of liver biopsy diagnosis in relation to the size of the specimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Sources of variability in histological scoring of chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Host genetic factors influence disease progression in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Polymorphisms of the renin-angiotensin system and the severity of fibrosis in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Polymorphism in alcohol-metabolizing enzymes, glutathione S-transferases and apolipoprotein E and susceptibility to alcohol-induced cirrhosis and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Diagnosis, management, and treatment of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Progression of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Natural history of initially mild chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Serum markers detect the presence of liver fibrosis: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Sampling variability of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Liver biopsy size matters in chronic hepatitis: bigger is better.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Effect of ALDH2 and CYP2E1 gene polymorphisms on drinking behavior and alcoholic liver disease in Japanese male workers

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087461

Noninvasive prediction of fibrosis in patients with chronic hepatitis C

29 October 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3682

Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis

21 January 2018

1 reference

12 December 2020

Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C

1 reference

12 December 2020

Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease

1 reference

12 December 2020

Tru-cut and Menghini needles: different yield in the histological diagnosis of liver disease

1 reference

12 December 2020

Diagnostic value of serum type IV collagen test in comparison with platelet count for predicting the fibrotic stage in patients with chronic hepatitis C

1 reference

12 December 2020

Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis

1 reference

12 December 2020

Validation of a simple predictive model for the identification of mild hepatic fibrosis in chronic hepatitis C patients

1 reference

12 December 2020

Basement membrane peptides as markers of liver disease in chronic hepatitis C

1 reference

12 December 2020

Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis

1 reference

12 December 2020

Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver

1 reference

12 December 2020

Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients

1 reference

12 December 2020

Histological grading and staging in chronic hepatitis: clinical applications and problems

1 reference

12 December 2020

Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C

1 reference

12 December 2020

Experts' opinions on the role of liver biopsy in HCV infection: A Delphi survey by the Italian Association of Hospital Gastroenterologists (A.I.G.O.)

1 reference

12 December 2020

Polymorphisms in alcohol metabolizing enzyme genes and alcoholic cirrhosis in Japanese patients: a multivariate analysis

1 reference

12 December 2020

Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C

1 reference

12 December 2020

[Medical practices and expectations of general practitioners in relation to hepatitis C virus infection in the Auvergne region]

1 reference

12 December 2020

EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement

1 reference

12 December 2020

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease

1 reference

12 December 2020

HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity

1 reference

12 December 2020

Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies

1 reference

12 December 2020

Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis

1 reference

12 December 2020

Analytical variability of the Fibrotest proteins

1 reference

12 December 2020

Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group

1 reference

12 December 2020

Ultrasound-assisted percutaneous liver biopsy performed by a physician assistant

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V12.I23.3682

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

PubMed ID

16773685